ISTH 2025: Elevating Levels of Endogenous Circulating von Willebrand Factor (VWF): The Potential of HMB-002 as a Prophylactic Treatment of Von Willebrand Disease (VWD)
Presented at the ISTH (International Society on Thrombosis and Haemostasis) 2025 Congress
To view the presentation, click here